Xiaogang Li Selected Research

Xiaogang Li Research Topics

Disease

31	Neoplasms (Cancer) 01/2022 - 07/2007
24	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2022 - 03/2002
17	Cysts 01/2022 - 08/2008
9	Fibrosis (Cirrhosis) 01/2022 - 01/2015
8	Inflammation (Inflammations) 07/2021 - 11/2012
6	Colorectal Neoplasms (Colorectal Cancer) 04/2022 - 07/2007
6	Pancreatic Neoplasms (Pancreatic Cancer) 06/2020 - 04/2006
5	Hypertension (High Blood Pressure) 01/2021 - 01/2014
5	Ischemic Stroke 01/2020 - 04/2014
4	Kidney Diseases (Kidney Disease) 01/2022 - 01/2019
4	Hepatocellular Carcinoma (Hepatoma) 12/2021 - 04/2016
4	Polycystic Kidney Diseases (Polycystic Kidney Disease) 03/2021 - 02/2003
3	COVID-19 11/2021 - 02/2021
3	Sepsis (Septicemia) 07/2021 - 01/2018
3	Brain Ischemia (Cerebral Ischemia) 05/2020 - 07/2013
3	Breast Neoplasms (Breast Cancer) 01/2018 - 09/2007
2	Cystic Kidney Diseases (Cystic Kidney Disease) 01/2022 - 01/2021
2	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2020
2	Pathologic Constriction (Stenosis) 01/2022 - 11/2018
2	Lymphatic Metastasis 01/2022 - 07/2007
2	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2020
2	Reperfusion Injury 01/2022 - 01/2015
2	Insulin Resistance 01/2022 - 01/2013
2	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2021 - 08/2018
2	Cardiovascular Diseases (Cardiovascular Disease) 02/2021 - 04/2014
2	Infections 02/2021 - 01/2017
2	Diabetes Complications 01/2021 - 11/2019
2	Adenocarcinoma of Lung 01/2021 - 01/2021
2	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 04/2014
2	Metabolic Diseases (Metabolic Disease) 12/2020 - 12/2018
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2020 - 01/2018
2	Carcinogenesis 12/2020 - 01/2018
2	Atherosclerosis 11/2020 - 12/2018
2	Nausea 08/2020 - 01/2016
2	Headache (Headaches) 08/2020 - 01/2016
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 07/2020 - 07/2015
2	Stroke (Strokes) 01/2020 - 12/2019
2	Cerebral Infarction 01/2020 - 12/2019
2	Liver Neoplasms (Liver Cancer) 01/2019 - 04/2016
2	Autosomal Recessive Polycystic Kidney (Polycystic Kidney Disease, Infantile, Type I) 12/2018 - 04/2007
2	Ciliopathies 10/2017 - 03/2014

Drug/Important Bio-Agent (IBA)

25	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2003
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2019
8	EnzymesIBA 01/2022 - 01/2012
6	Lysine (L-Lysine)FDA Link 01/2022 - 06/2017
5	AntioxidantsIBA 01/2022 - 02/2015
5	MethyltransferasesIBA 01/2022 - 06/2017
5	Circular RNAIBA 01/2022 - 01/2018
4	Messenger RNA (mRNA)IBA 01/2022 - 07/2013
4	RNA (Ribonucleic Acid)IBA 11/2021 - 01/2015
4	MicroRNAs (MicroRNA)IBA 03/2021 - 01/2020
4	renalaseIBA 01/2021 - 01/2014
4	Transcription Factors (Transcription Factor)IBA 06/2020 - 01/2017
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2020
3	Small Interfering RNA (siRNA)IBA 01/2022 - 09/2017
3	salicylhydroxamic acid (SHAM)IBA 01/2022 - 01/2018
3	CytokinesIBA 11/2021 - 08/2008
3	Long Noncoding RNAIBA 01/2021 - 11/2017
3	Niacinamide (Nicotinamide)FDA LinkGeneric 08/2020 - 07/2013
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 02/2015
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015 - 08/2008
3	Histone Deacetylase InhibitorsIBA 01/2012 - 04/2010
3	Histone Deacetylases (Histone Deacetylase)IBA 01/2012 - 04/2010
3	TRPP Cation ChannelsIBA 04/2010 - 03/2002
2	IronIBA 01/2022 - 11/2021
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2022 - 04/2016
2	Histones (Histone)IBA 01/2022 - 01/2019
2	ParaffinIBA 01/2022 - 01/2020
2	erucylphosphocholineIBA 01/2022 - 01/2018
2	Cadherins (E-Cadherin)IBA 01/2022 - 01/2018
2	Fibronectins (Fibronectin)IBA 01/2022 - 01/2022
2	CollagenIBA 01/2022 - 01/2022
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2021 - 11/2020
2	Indicators and Reagents (Reagents)IBA 11/2021 - 02/2021
2	ThrombomodulinIBA 11/2021 - 02/2021
2	von Willebrand FactorIBA 11/2021 - 02/2021
2	Interleukin-2 (IL2)IBA 11/2021 - 01/2017
2	AlbuminsIBA 02/2021 - 03/2019
2	Interleukin-6 (Interleukin 6)IBA 02/2021 - 06/2017
2	fibrin fragment D (D-dimer)IBA 02/2021 - 11/2019
2	ProteomeIBA 01/2021 - 07/2007
2	Protein Kinases (Protein Kinase)IBA 01/2021 - 10/2017
2	FlavoproteinsIBA 01/2021 - 01/2015
2	Pharmaceutical PreparationsIBA 01/2021 - 12/2016
2	HomocysteineIBA 07/2020 - 01/2020
2	ChromatinIBA 06/2020 - 01/2019
2	ProgranulinsIBA 05/2020 - 01/2020
2	Antihypertensive Agents (Antihypertensives)IBA 04/2020 - 06/2019
2	Lipoproteins (Lipoprotein)IBA 12/2018 - 01/2015
2	Iodine-125IBA 12/2017 - 11/2013
2	NAD (NADH)IBA 10/2017 - 07/2013
2	TransferasesIBA 10/2017 - 01/2016

Therapy/Procedure

11	Therapeutics 01/2022 - 12/2013
4	Punctures 07/2021 - 01/2018
3	Drug Therapy (Chemotherapy) 12/2020 - 10/2017
2	Subcutaneous Injections 11/2021 - 10/2017
2	Ligation 07/2021 - 01/2018
2	Thrombectomy 01/2020 - 12/2019
2	Length of Stay 01/2020 - 11/2018
2	Endovascular Procedures 01/2020 - 12/2019